CAR T-cell therapy in prostate cancer: Early results and ongoing trials

Tanya Dorff, MD, discusses early results with CAR T-cell therapy in patients with prostate cancer and describes ongoing clinical trials exploring the treatment in this setting. Dorff is a medical oncologist, section chief of Genitourinary Disease Program, and associate professor in the Department of Medical Oncology & Therapeutics Research at City of Hope Comprehensive Cancer Center.